World Class Melanoma Doctors to Lead This Year’s International Forum
(Cranbury NJ-January 31, 2017) – Physicians’ Education Resource® (PER®), will host the 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® on Feb. 11 at Trump International Miami. The program will be led by Co-Chairs Dr. Jeffrey S. Weber, deputy director of the Laura and Issac Perlmutter Cancer Center and professor of medicine at NYU’s Langone Medical Center, and Dr. Omid Hamid, chief of translational and immuno-oncology and director of cutaneous malignancies at the Angeles Clinic and Research Institute and Director of Experimental Therapeutics at Cedars Sinai Medical Care Foundation in Los Angeles.
In making the announcement, Dr. Jeffery S. Weber said: “We have just begun to scratch the surface in the process of developing the innovative techniques and therapies that we can use to fight cutaneous malignancies. Interactive forums like the current one allow those on the front lines to collaborate in order to propel the right initiatives forward to improve patient care.”
The one-day educational meeting’s focal point will be on contemporary approaches and the future of direction of therapy in the management of melanoma and other cutaneous malignancies, and contains a fast-paced forum on key core areas of personalizing care for melanoma tumors including immunotherapies, targeted therapies, regional therapy, predictive/prognostic modeling, and integrated medicine/patient care.
The symposium will be held at the Trump International Miami on Feb. 11 in Sunny Isles Beach, Florida, located 3.5 miles from the Miami International Airport and 13 miles from the Fort Lauderdale International Airport. For more information and to register please visit: gotoper.com/go/RegisterIME
Since 1995, PER has been the educational resource of choice for live and online activities focusing on oncology and hematology. PER provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. Activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. With the rapid advances occurring in the field of oncology, understanding how to use molecular data to diagnose and stage patients, selecting the most appropriate candidates for novel therapeutic agents, individualizing treatment based on tumor type, and referring patients to clinical trials will continue to ensure the highest level of patient care is provided. PER serves the oncology healthcare community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists, and researchers. PER is part of the Cranbury, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com